Genenta to present preliminary Phase I/II clinical data on Temferon™ in glioblastoma multiforme at Chardan’s 4th Annual Genetic Medicines Conference

Matt Turner
Patient Affordability

Suma Ramadas, PhD
Medical Affairs

Frank Burrell
Scientific Storytelling

Daniel Sontupe
Market Access

Liz Kane
Impactful Strategy

Paul Theisen
Patient Acquisition

Brenda Snow
Authentic Patient Voice

Matthew Durham
Omnidynamic Marketing

Pat Purcell
Meeting Engagement

Joey Cohen
Medication Adherence

David Linetsky
Point-of-Care Marketing

Stacey Gandler
Brand Nourishment

Amy Giles
Increasing Engagement

Bud Bilanich
Success Coach